Long-term molecular remission after treatment with imatinib in a chronic myeloid leukemia patient with extreme thrombocytosis harboring rare e14a3 (b3a3) bcr::abl1 transcript: a case report

HIGHLIGHTS

• who: Xupai Zhang and colleagues from the Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China have published the article: Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report, in the Journal: (JOURNAL)
• what: The authors report case of CML (41 years female) with extreme at onset with the variant Ph chromosome and e14a3 (b3a3) BCR::ABL1
• how: A persistent >1000 u00d7 10 patient department and the molecular platelet responsecount was evaluated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.